New laboratory findings in Turkish patients with transient hypogammaglobulinemia of infancy
- PMID: 21131704
New laboratory findings in Turkish patients with transient hypogammaglobulinemia of infancy
Abstract
Transient hypogammaglobulinemia (THI) of infancy is a common primary immunodeficiency usually resolves by 3 years of age. In this study, clinical, immunological data and outcome of 101 retrospectively diagnosed THI patients were evaluated. Majority of them suffered from recurrent respiratory infections (70.3%). Initial IgG, IgM and IgA levels were 446.7±121.5, 67.5±32.8, and 25.6±16.8 mg/dl, respectively. Patients who had lower IgG levels on admission reached normal IgG levels earlier than others. Infants who were retarded to reach age-related normal levels for IgM and IgA were found to have higher CD3+CD8+ T cells on admission. During immunoglobulin abnormalities, mean lymphocyte subset percentages and absolute counts were normal. Mean percentage of CD19+CD27+ memory B cells was 3.4±1.4% which is not significantly different from healthy children. Most of the children had protective antibody responses to tetanus (87%) and Haemophilus influenzae type B (85.7%) vaccines. Patients with low anti-tetanus responses had higher initial natural killer (NK) cell percentages probably due to recurrent viral infections or relative dominance of innate responses. Follow-up of patients with initially high NK were found to have longer duration of deficiency hence these patients' recoveries were delayed. During follow-up, 91/101 (90.1%) children produced normali levels of IgG at the end of 29.2 ± 15.2 months. The results of this study indicate that some children will achieve normal levels of IgG within 30 months of age, and some will remain IgG subclass or IgA deficient. Determination of increased NK percentages in patients with non-protective vaccine response and normal percentages of memory B cells are noteworthy novel findings.
Similar articles
-
Impaired specific antibody response and increased B-cell population in transient hypogammaglobulinemia of infancy.Ann Allergy Asthma Immunol. 2006 Nov;97(5):590-5. doi: 10.1016/S1081-1206(10)61085-X. Ann Allergy Asthma Immunol. 2006. PMID: 17165264
-
A case of IgG subclass deficiency with the initial presentation of transient hypogammaimmuno-globulinemia of infancy and a review of IgG subclass deficiencies.J Med Assoc Thai. 2003 Jul;86(7):686-92. J Med Assoc Thai. 2003. PMID: 12948264
-
Transient hypogammaglobulinemia and unclassified hypogammaglobulinemia: 'similarities and differences'.Pediatr Allergy Immunol. 2010 Aug;21(5):843-51. doi: 10.1111/j.1399-3038.2010.01010.x. Epub 2010 Jul 1. Pediatr Allergy Immunol. 2010. PMID: 20609138
-
[Cytokines in children with immunodeficiencies].Folia Med Cracov. 1999;40(1-2):5-97. Folia Med Cracov. 1999. PMID: 10909468 Review. Polish.
-
IgG subclass deficiencies and recurrent pyogenic infections, unresponsiveness against bacterial polysaccharide antigens.Allergol Immunopathol (Madr). 1992 Jan-Feb;20(1):28-34. Allergol Immunopathol (Madr). 1992. PMID: 1509985 Review.
Cited by
-
Phenotypic parameters predict time to normalization in infants with hypogammaglobulinemia.J Clin Immunol. 2013 Nov;33(8):1336-40. doi: 10.1007/s10875-013-9937-7. Epub 2013 Sep 8. J Clin Immunol. 2013. PMID: 24014079
-
Primary Immunodeficiencies in Children Initially Admitted with Gastrointestinal/Liver Manifestations.Pediatr Gastroenterol Hepatol Nutr. 2023 Jul;26(4):201-212. doi: 10.5223/pghn.2023.26.4.201. Epub 2023 Jul 5. Pediatr Gastroenterol Hepatol Nutr. 2023. PMID: 37485029 Free PMC article.
-
Periodontal and other oral manifestations of immunodeficiency diseases.Oral Dis. 2017 Oct;23(7):866-888. doi: 10.1111/odi.12584. Epub 2016 Oct 10. Oral Dis. 2017. PMID: 27630012 Free PMC article. Review.
-
The B-cell compartment in antibody-deficient infants and young children - developing common variable immunodeficiency or transient immune maturation?Ital J Pediatr. 2016 Jul 26;42(1):71. doi: 10.1186/s13052-016-0279-y. Ital J Pediatr. 2016. PMID: 27461226 Free PMC article.
-
Clinical and experimental treatment of primary humoral immunodeficiencies.Clin Exp Immunol. 2024 Apr 23;216(2):120-131. doi: 10.1093/cei/uxae008. Clin Exp Immunol. 2024. PMID: 38306460 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous